Assistance Fund: Ankylosing Spondylitis: Waitlist

Funded
About
The Assistance Fund: Ankylosing Spondylitis: Waitlist helps patients with Ankylosing Spondylitis access essential treatments. With coverage for a wide range of drugs like Cimzia, Cosentyx, Enbrel, and Humira, this program provides financial aid for copays, coinsurance, and out-of-pocket medical expenses. Assistance Fund: Ankylosing Spondylitis: Waitlist is designed to ease the financial burden on patients, ensuring they receive the necessary care throughout the year, conditional upon available funding.
Insurance requirements: Commercially insured, Medicare / Medicaid
Enrollment Forms
Assistance Fund: Ankylosing Spondylitis: Waitlist
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Please note the following:
1. Copay grant programs provide assistance for copays, coinsurance, and deductibles for FDAapproved treatment for the disease named in the disease program ONLY
2. Financial assistance grant programs provide assistance for other eligible outofpocket costs, such as health insurance premiums and incidental medical expenses, in addition to copay, coinsurance, and deductible assistance on FDAapproved treatment for the disease named in the disease program
3. This fund may cover offlabel drugs
Copay and Financial assistance can be utilized by any innetwork pharmacy or site of care able to dispense the medication or provide treatment
Program offers conditional approval of 30 days of immediate assistance for open programs where funding is available
Patients will be asked to provide and verify demographic, insurance, and financial information (additional documentation may be requested)
Approved patients will be granted assistance through the end of the calendar year unless otherwise specified for the applicable program
Other Tools for Taltz